FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034382093> ?p ?o ?g. }

• W2034382093 endingPage "772" @default.
• W2034382093 startingPage "765" @default.
• W2034382093 abstract "A chronic relapsing form of experimental autoimmune encephalomyelitis (CR-EAE) was induced in SJL/J mice by adoptive transfer of lymph node cells (LNC) sensitized to guinea pig myelin basic protein (GMBP). We examined the efficacy of high dose immunosuppressive regimens (cyclophosphamide [CY] 300 mg/kg or total body irradiation [TBI] 900 cGy) followed by syngeneic bone marrow transplantation (SBMT) in prevention and treatment of already established CR-EAE. Treatment with TBI and SBMT on day 5 after the induction of CR-EAE, just before the onset of clinical signs, completely inhibited the appearance of the paralytic signs. The same treatment, applied 4 d after the clinical onset of the disease, led to a significant regression of the paralytic signs and to a total inhibition of spontaneous relapses during a follow-up period of 2 mo. Challenge of mice with GMBP+CFA 78 d after the passive induction of CR-EAE induced a relapse of the disease 7 d later in almost all of the untreated mice; in contrast, the same challenge given to TBI+SBMT-treated mice caused a delayed relapse (30 d later) in only a minority (3/7) of the challenged mice. In vitro lymphocytic proliferative responses to GMBP and purified protein derivative were significantly lower in TBI/SBMT-treated mice before and after the GMBP challenge, although these mice were fully immunocompetent, as evidenced by their normal lymphocytic proliferation to concanavalin A (ConA) and the FACS analysis of their lymphocytic subpopulations. A similar beneficial therapeutic effect was observed in mice treated with CY followed by SBMT, after the onset of CR-EAE. Our results could support possible clinical applications of similar therapeutic strategies, involving acute immunosuppression followed by stem cell transplantation and retolerization of the reconstituting immune cells in life-threatening neurological and multisystemic autoimmune diseases." @default.
• W2034382093 created "2016-06-24" @default.
• W2034382093 creator A5007797445 @default.
• W2034382093 creator A5014241454 @default.
• W2034382093 creator A5015657745 @default.
• W2034382093 creator A5018290889 @default.
• W2034382093 creator A5042549087 @default.
• W2034382093 creator A5059195767 @default.
• W2034382093 creator A5059915616 @default.
• W2034382093 creator A5090041454 @default.
• W2034382093 date "1993-08-01" @default.
• W2034382093 modified "2023-10-02" @default.
• W2034382093 title "Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation." @default.
• W2034382093 cites W1483769055 @default.
• W2034382093 cites W1483986250 @default.
• W2034382093 cites W1497008251 @default.
• W2034382093 cites W1504285588 @default.
• W2034382093 cites W1516355799 @default.
• W2034382093 cites W1527431993 @default.
• W2034382093 cites W1567183081 @default.
• W2034382093 cites W1607532672 @default.
• W2034382093 cites W1624101748 @default.
• W2034382093 cites W1654809115 @default.
• W2034382093 cites W1753278267 @default.
• W2034382093 cites W1855797846 @default.
• W2034382093 cites W1921745771 @default.
• W2034382093 cites W1969149994 @default.
• W2034382093 cites W1970430412 @default.
• W2034382093 cites W1974821266 @default.
• W2034382093 cites W1981177592 @default.
• W2034382093 cites W1988802610 @default.
• W2034382093 cites W1989887874 @default.
• W2034382093 cites W2000776709 @default.
• W2034382093 cites W2004110862 @default.
• W2034382093 cites W2012986854 @default.
• W2034382093 cites W2031641115 @default.
• W2034382093 cites W2035006350 @default.
• W2034382093 cites W2042055196 @default.
• W2034382093 cites W2063266492 @default.
• W2034382093 cites W2064074772 @default.
• W2034382093 cites W206849749 @default.
• W2034382093 cites W2071284269 @default.
• W2034382093 cites W2081876067 @default.
• W2034382093 cites W2095029406 @default.
• W2034382093 cites W2095447862 @default.
• W2034382093 cites W2111718562 @default.
• W2034382093 cites W2121015743 @default.
• W2034382093 cites W2127263225 @default.
• W2034382093 cites W2155641659 @default.
• W2034382093 cites W2395390106 @default.
• W2034382093 cites W2399924850 @default.
• W2034382093 cites W2406248124 @default.
• W2034382093 cites W2409141921 @default.
• W2034382093 cites W2410982626 @default.
• W2034382093 cites W2414387582 @default.
• W2034382093 cites W2415866215 @default.
• W2034382093 cites W2419619465 @default.
• W2034382093 cites W2474510038 @default.
• W2034382093 cites W46845688 @default.
• W2034382093 doi "https://doi.org/10.1172/jci116648" @default.
• W2034382093 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/294912" @default.
• W2034382093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7688762" @default.
• W2034382093 hasPublicationYear "1993" @default.
• W2034382093 type Work @default.
• W2034382093 sameAs 2034382093 @default.
• W2034382093 citedByCount "114" @default.
• W2034382093 countsByYear W20343820932012 @default.
• W2034382093 countsByYear W20343820932013 @default.
• W2034382093 countsByYear W20343820932014 @default.
• W2034382093 countsByYear W20343820932015 @default.
• W2034382093 countsByYear W20343820932016 @default.
• W2034382093 countsByYear W20343820932017 @default.
• W2034382093 countsByYear W20343820932018 @default.
• W2034382093 countsByYear W20343820932019 @default.
• W2034382093 countsByYear W20343820932020 @default.
• W2034382093 countsByYear W20343820932021 @default.
• W2034382093 countsByYear W20343820932022 @default.
• W2034382093 crossrefType "journal-article" @default.
• W2034382093 hasAuthorship W2034382093A5007797445 @default.
• W2034382093 hasAuthorship W2034382093A5014241454 @default.
• W2034382093 hasAuthorship W2034382093A5015657745 @default.
• W2034382093 hasAuthorship W2034382093A5018290889 @default.
• W2034382093 hasAuthorship W2034382093A5042549087 @default.
• W2034382093 hasAuthorship W2034382093A5059195767 @default.
• W2034382093 hasAuthorship W2034382093A5059915616 @default.
• W2034382093 hasAuthorship W2034382093A5090041454 @default.
• W2034382093 hasBestOaLocation W20343820931 @default.
• W2034382093 hasConcept C126322002 @default.
• W2034382093 hasConcept C203014093 @default.
• W2034382093 hasConcept C2776090121 @default.
• W2034382093 hasConcept C2776694085 @default.
• W2034382093 hasConcept C2776755627 @default.
• W2034382093 hasConcept C2777899865 @default.
• W2034382093 hasConcept C2778486448 @default.
• W2034382093 hasConcept C2778609137 @default.
• W2034382093 hasConcept C2778880498 @default.
• W2034382093 hasConcept C2779263901 @default.
• W2034382093 hasConcept C2780007613 @default.

• next